RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Burbank, CA · La Palma, CA · Westlake Village, CA · +22 more sites